Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Editas Medicine (EDIT)

Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce Zacks Investment Research - Mon Dec 16, 10:48AM CST

Shares of Editas Medicine EDIT plunged 23.8% on Dec. 13 after it announced a strategic decision to end the development of its lead gene editing therapy, reni-cel, following the failure of an extensive...

CTMX : 1.0900 (-0.91%)
CSTL : 27.53 (+1.62%)
EDIT : 1.3100 (-2.24%)
SPRO : 0.9551 (-4.30%)
Editas Medicine Advances In Vivo CRISPR-Edited Medicines, Announces Workforce Reduction and Strategic Transition Quiver Quantitative, Inc. - Fri Dec 13, 1:24AM CST

Editas Medicine announces advancements in in vivo CRISPR gene editing, optimizing costs, and reducing workforce while focusing on hematologic diseases.Quiver AI SummaryEditas Medicine, Inc. has announced...

EDIT : 1.3100 (-2.24%)
Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years GlobeNewswire - Thu Dec 12, 3:00PM CST

EDIT : 1.3100 (-2.24%)
Editas Medicine Presents Promising Results for Reni-Cel in Severe Sickle Cell Disease at ASH Annual Meeting Quiver Quantitative, Inc. - Mon Dec 9, 9:22PM CST

Editas Medicine presents promising data on reni-cel for severe sickle cell disease at ASH, showing safety and improved hemoglobin levels.Quiver AI SummaryEditas Medicine announced that it will present...

EDIT : 1.3100 (-2.24%)
Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting GlobeNewswire - Mon Dec 9, 11:00AM CST

EDIT : 1.3100 (-2.24%)
Medicine labratory by gorodenkoff via iStock
1 Penny Stock to Grab Now for 183% Upside Potential Barchart - Thu Nov 7, 3:31PM CST

This biotech penny stock could more than triple, based on consensus forecasts.

VRTX : 397.27 (+0.16%)
EDIT : 1.3100 (-2.24%)
BMY : 57.33 (+1.83%)
Editas Medicine to Participate in Upcoming Investor Conferences GlobeNewswire - Wed Nov 6, 8:00AM CST

EDIT : 1.3100 (-2.24%)
Editas: Q3 Earnings Snapshot AP - Mon Nov 4, 6:36AM CST

Editas: Q3 Earnings Snapshot

EDIT : 1.3100 (-2.24%)
Editas Medicine Announces Third Quarter 2024 Results and Business Updates GlobeNewswire - Mon Nov 4, 6:30AM CST

EDIT : 1.3100 (-2.24%)
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and Strategic Update GlobeNewswire - Tue Oct 22, 6:00AM CDT

EDIT : 1.3100 (-2.24%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 29 minutes ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot